Skip to main content

Fulcrum Therapeutics, Inc.

FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001680581

In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Fulcrum Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of FULC: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1302119−9
Shares54.9M223.7K51.7M−2.97M (−5.4%)
Value$196.4M$798.6K$243.4M+$47.8M (+24.4%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to FULC in Q4 2024
InstitutionSharesValue% of portfolio
Exome Asset Management LLC283,599$1.33M1.00%
Perceptive Advisors LLC238,000$1.12M0.03%
Susquehanna Fundamental Investments, LLC213,213$1.00M0.02%
Bridgeway Capital Management, LLC140,000$658.0K0.01%
State Board of Administration of Florida Retirement System130,693$614.3K0.00%
LMR Partners LLP112,500$528.8K0.01%
Altium Capital Management LP111,812$525.5K0.16%
HRT Financial LP68,069$319.0K0.00%
MYDA Advisors LLC63,970$300.7K0.09%
Bailard, Inc.35,900$168.7K0.00%
Zacks Investment Management20,999$98.7K0.00%
Cantor Fitzgerald, L. P.20,000$94.0K0.00%
Mariner, LLC16,516$77.6K0.00%
Jain Global LLC15,409$72.4K0.00%
Police & Firemen's Retirement System of New Jersey12,475$58.6K0.00%
BNP Paribas Arbitrage, SA8,014$37.7K0.00%
Skopos Labs, Inc.3,936$18.5K0.01%
Belvedere Trading LLC758$3.56K0.00%
Caitong International Asset Management Co., Ltd145$6820.00%
C M Bidwell & Associates Ltd117$5500.00%
HighMark Wealth Management LLC100$4700.00%
SBI Securities Co., Ltd.26$1220.00%
Larson Financial Group LLC15$710.00%
The PNC Financial Services Group, Inc.5$240.00%

Sold out (33)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FULC in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Mass General Brigham, Inc205,356$733.1K
AJOVista, LLC18,349$65.5K